Page 3 - Numinus Bioscience News Today

/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and...

/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and...

Interest in and usage of psilocybin is spreading like the threads of underground mycelium.

/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and...

FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Oct. 5, 2022 /PRNewswire/ -- A new study undertaken by experts at John Hopkins University School of Medicine has revealed

/PRNewswire/ -- A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same...

FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Sept. 1, 2022 /PRNewswire/ -- Young adults are using more hallucinogens than ever. According to a National Institute

/PRNewswire/ -- Young adults are using more hallucinogens than ever. According to a National Institute of Health survey, the amount of people between age 19 to...

Numinus Wellness Inc. (OTCQX:NUMIF) Q3 2022 Earnings Conference Call July 14, 2022, 5:30 PM ET Company Participants Jamie Kokoska - Vice President, Investor Relations Payton Nyquvest -...

Revenues grew 32% year-over-year to $0.74 million for the quarter Clinic network revenues grew 59.5% from the same quarter last year and 7.5% compared to prior...